Sarcura

Austria · Biotechnology

Cell therapy has transformed cancer treatment, yet the hurdles of manufacturing patient-derived cell therapies remain a formidable challenge for the industry. Quality and scalability problems lead to high therapeutic costs and limit access to those life-saving treatments. By harnessing the power of cutting-edge semiconductor technologies, including silicon photonics seamlessly integrated into microfluidic cartridges, Sarcura is orchestrating a transformative shift. Central to Sarcura's mission is the creation of fully automated manufacturing systems endowed with real-time process and product control. This pioneering platform promises to usher in a new era of cost-effective and secure cell therapies, democratizing access to these critical treatments. We aim for a 100x production boost and 10x cost reduction, driving the industrialization of cell therapy manufacturing. Delve deeper at www.sarcura.com, where the future of cancer treatment is being reshaped.